O'Melveny & Myers, Tian Yuan Law Firm and William Ji & Co. have represented China’s Simcere Pharmaceutical Group on its HK$3.57 billion ($460.6 million) Hong Kong IPO, with Herbert Smith Freehills and Jingtian & Gongcheng advising the joint sponsors.

The listing is the latest by a Chinese biopharmaceutical company in Hong Kong, which is on track to have its second-busiest year for equity capital markets ever in 2020. Recent such issuers include JHBP (CY) Holdings and Everest Medicines.

Simcere Pharmaceutical supplies branded generic pharmaceuticals to the Chinese market. It has increased investment in R&D in recent years, and has three R&D centres in Nanjing, Shanghai and Boston.

Partners Matt Emsley, Siddhartha Sivaramakrishnan and Stanley Xie led the Herbert Smith Freehills team.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com. 

Related Articles

Deals

SAM, Luthra, Simmons guide planned $360 mln India renewable energy IPO

by Asian Legal Business《亚洲法律杂志》 |

Shardul Amarchand Mangaldas & Co is advising Indian renewable energy firm ACME Solar Holdings on its planned 30-billion-rupee ($360 million) initial public offering, with Luthra & Luthra Law Offices and Simmons & Simmons representing the book-running lead managers.

Deals

Paul Hastings advises Korean gaming firm on $315 mln IPO

by Asian Legal Business《亚洲法律杂志》 |

U.S. law firm Paul Hastings has advised Tencent-backed South Korean gaming company Shift Up on its 435-billion-won ($315 million) initial public offering on the Korea Exchange.

Deals

Latham, Links advise on Malaysia's largest IPO in 2 years

by Asian Legal Business《亚洲法律杂志》 |

Latham & Watkins and Mah-Kamariyah & Philip Koh have advised Malaysian palm oil company Johor Plantations Group on its 735-million-ringgit ($157 million) initial public offering, the country's biggest in more than two years.